Ignite Creation Date:
2024-05-06 @ 4:15 PM
Last Modification Date:
2024-10-26 @ 2:07 PM
Study NCT ID:
NCT04927793
Status:
COMPLETED
Last Update Posted:
2022-03-23
First Post:
2021-06-09
Brief Title:
Absorption Metabolism and Excretion AME Study of 14CEDP-938 in Healthy Male Subjects
Sponsor:
Enanta Pharmaceuticals Inc
Organization:
Enanta Pharmaceuticals Inc
Study Overview
Official Title:
A Phase I Open-label Study of the Absorption Metabolism and Excretion of 14CEDP-938 Following a Single Oral Dose in Healthy Male Subjects
Status:
COMPLETED
Status Verified Date:
2022-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A Phase 1 Open-label Study of the absorption metabolism and excretion of a single oral dose of 14CEDP-938 in healthy male subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None